VOLEZE 9.5 MG / 24 H TRANSDERMAL PATCH - patient leaflet, side effects, dosage

NJ

U)

BACK

Rivastigmine

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

– Keep this leaflet. You may need to read it again.

– If you have any further questions, ask your doctor, pharmacist or nurse.

– This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

– If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

• 1. What Voleze is and what it is used for

• 2. What you need to know before you use Voleze

• 3. How to use Voleze

• 4. Possible side effects

• 5. How to store Voleze

• 6. Contents of the pack and other information

Always use this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.

IMPORTANT:

• Take off the previous patch before putting ONE new patch on
• Only one patch per day
• Do not cut the patch into pieces
• Press the patch firmly in place for at least 30 seconds using the palm of the hand.

How to start treatment

Your doctor will tell you which Voleze transdermal patch is most suitable for you.

• Treatment usually starts with Voleze 4.6 mg/24 h
• The usual daily dose is Voleze 9.5 mg/24 h
• Only wear one Voleze patch at a time and replace the patch with a new one after 24 hours.

During the course of the treatment your doctor may adjust the dose to suit your individual needs.

If you have not applied a Voleze patch for three days, do not apply the next one before you have talked to your doctor.

Where to apply your Voleze transdermal patch

• Before you apply a patch, make sure that your skin is clean, dry and hairless, free of any powder, oil, moisturiser or lotion that could keep the patch from sticking to your skin properly, free of cuts, rashes and/or irritations.
• Carefully remove any existing patch before putting on a new one.

Having multiple patches on your body could expose you to an excessive amount of this medicine which could be potentially dangerous.

• Apply ONLY ONE patch per day to ONLY ONE of the possible locations shown in the following diagrams:

– left upper arm or right upper arm

– left upper chest or right upper chest (avoid breast)

– left upper back or right upper back

– left lower back or right lower back.

Every 24 hours take off the previous patch before putting ONE new patch on to ONLY ONE of the following possible locations.

sources (e.g. excessive sunlight, saunas, solarium) for long periods of time.

What to do if a patch falls off

If a patch falls off, apply a new one for the rest of the day, then replace it at the same time as usual the next day.

When and for how long to apply your Voleze transdermal patch

• To benefit from treatment, you must apply a new patch every day, preferably at the same time of day.
• Only wear one Voleze patch at a time and replace the patch with a new one after 24 hours.

If you use more Voleze than you should

If you accidentally apply more than one patch, remove all the patches from your skin, then inform your doctor that you have accidentally applied more than one patch. You may require medical attention. Some people who have accidentally taken too much rivastigmine have experienced feeling sick (nausea), being sick (vomiting), diarrhoea, high blood pressure and hallucinations. Slow heart beat and fainting may also occur.

If you forget to use Voleze

If you find you have forgotten to apply a patch, apply one immediately. You may apply the next patch at the usual time the next day. Do not apply two patches to make up for the one that you missed.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:. By reporting side effects you can help provide more information on the safety of this medicine.

Version No.: Product Name:

Pack Size: Component:

SKU:

Market:

Production Site:

Revision No.:

Revision Date:

Revised by: CRF:

103487–88/LF/314/02

10, 30, 60&90 Leaflet 103487–88 UK

Klocke Verpackungs -Service GmbH

5 10/11/2016

ADD

AMCo.CRF.377.2015

Do not use Voleze

CD

QJ “! CD CU

– if you are allergic to rivastigmine or any of the other ingredients of this medicine (listed in section 6)

– if you have ever had an allergic reaction to a similar type of medicine (carbamate derivatives)

– if you have a skin reaction spreading beyond the patch size, if there is a more intense local

—reoc4ien- -(such- es- blisters,–increasing- -skininflammation, swelling) and if it does not improve within 48 hours after removal of the transdermal patch.

If this applies to you, tell your doctor and do not apply Voleze transdermal patches.

Warnings and precautions

Talk to your doctor, pharmacist or nurse before using Voleze

– if you have or have ever had, irregular or slow heartbeat

– if you have or have ever had, an active stomach or duodenal ulcer

– if you have or have ever had, difficulties in passing urine

– if you have or have ever had, seizures

– if you have or have ever had, asthma or a severe respiratory disease

– if you suffer from trembling

– if you have a low body weight (less than 50 kg)

– if you have gastrointestinal reactions such as feeling sick (nausea), being sick (vomiting) and diarrhoea. You may become dehydrated (losing too much fluid) if vomiting or diarrhoea are prolonged

– if you have impaired liver function.

If any of these apply to you, your doctor may need to monitor you more closely while you are on this medicine.

If you have not applied a Voleze patch for three days, do not apply the next one before you have talked to your doctor.

When changing the patch, you must remove the previous day's patch before you apply the new one to a different location of skin each time (for example on the right side of your body one day, then on the left side the next day and on your upper body one day, then on your lower body the next day). Do not apply a new patch to that same skin area twice within 14 days.

How to apply your Voleze transdermal patch

Voleze patches are thin, translucent, plastic patches that stick to the skin. Each patch is sealed in a sachet that protects it until you are ready to put it on. Do not open the sachet or remove a patch until just before you apply it.

– Each patch is sealed in its own protective sachet. You should only open the sachet when you are ready to apply the patch. Cut the sachet along the

dotted line with scissors and remove the

patch from the sachet.

– A protective liner covers the sticky side of the patch. Peel off one side of the protective liner and do not touch the sticky part of the patch with the fingers.

Use in children and adolescents

There is no relevant use of Voleze in the paediatric population in the treatment of Alzheimer’s di­sease.

Other medicines and Voleze

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Voleze might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson’s disease or to prevent travel sickness).

If you have to undergo surgery whilst using Voleze transdermal patches, tell your doctor that you are using them because they may exaggerate the effects of some muscle relaxants during anaesthesia.

Voleze with food, drink and alcohol

Food, drink and alcohol do not affect the use of Voleze transdermal patches because rivastigmine enters the bloodstream through the skin.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

If you are pregnant, the benefits of using Voleze transdermal patches must be assessed against the possible effects on your unborn child. Voleze transdermal patches should not be used during pregnancy unless clearly necessary.

You should not breast-feed during treatment with Voleze transdermal patches.

Driving and using machines

Your doctor will tell you whether your illness allows

If you stop using Voleze

Tell your doctor or pharmacist if you stop using the patch.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

– Put the sticky side of the patch on the upper or lower back, upper arm or chest and then peel off the second side of the protective liner.

– Then press the patch firmly in place for at least 30 seconds using the palm of the hand to make sure that the edges stick well.

If it helps you, you may write, for example, the day of the week, on the patch with a thin ball point pen.

The patch should be worn continuously until it is time to replace it with a new one. You may wish to experiment with different locations when applying a new patch, to find ones that are most comfortable for you and where clothing will not rub on the patch

How to remove your Voleze transdermal patch

Gently pull at one edge of the patch to remove it slowly from the skin.

You should wash your hands with soap and water after removing the patch. In case of contact with eyes or if the eyes become red after handling the patch, rinse immediately with plenty of water and seek medical advice if symptoms do not resolve.

Can you wear your Voleze transdermal patch when you are bathing, swimming or in the sun?

• Bathing, swimming or showering should not affect the patch. Make sure the patch does not loosen during these activities.
• Do not expose the patch to any external heat (continued overleaf)

capsules or oral solutions which may occur with the patch:

Common (may affect up to 1 in 10 people)

• Too much saliva
• Loss of appetite
• Feeling restless
• Feeling agitated or sleepy
• Generally feeling unwell
• Trembling or feeling confused
• Increased sweating.

Uncommon (may affect up to 1 in 100 people)

• Uneven heart rate (e.g. fast heart rate)
• Difficulty sleeping
• Accidental falls.

Rare (may affect up to 1 in 1,000 people)

• Fits (seizures)
• Ulcer in the intestine
• Chest pain – this may be caused by heart spasm.

Very rare (may affect up to 1 in 10,000 people)

• High blood pressure
• Inflammation of the pancreas – the signs include serious upper stomach pain, often with feeling sick (nausea) or being sick (vomiting)
• Bleeding in the gut – shows as blood in stools or when being sick
• Some people who have been violently sick have had tearing of the tube that connects your mouth with your stomach (oesophagus).

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date, which is stated on the carton and sachet after ‚EXP‘. The expiry date refers to the last day of the month.

Store in the original package in order to protect from light.

Keep the transdermal patch in the sachet until use. This medicinal product does not require any special temperature storage conditions.

Do not use any patch that is damaged or shows signs of tampering.

After removing a patch, fold it in half with the sticky sides on the inside and press them together. Return the used patch to its sachet and dispose of it in such a way that children cannot handle it. Do not touch your eyes with your fingers and wash your hands with soap and water after removing the patch. If your community burns domestic rubbish, you can dispose of the patch with your domestic rubbish. Otherwise, return used patches to a pharmacy, preferably in the original packaging.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

This leaflet was last revised in November 2016.

103487–88/LF/314/02

10

Dimension: 540 × 170 mm

Commodity No.: N/A

Pharma Code: N/A Core Spec Ref: N/A

DCMF: N/A

Print Colours: Black

Non-Print Colours: Cutter

Tech App. Date: 11/11/2016

Min. Font Size: 9 pt

REGULATORY AUTHORITY APPROVAL CONFIRMATION

Confirmation that this artwork has been approved by the appropriate market authority (if applicable, e.g.

MHRA, HPRA, etc.) and that Amdipharm have license approval to distribute this component for sale in the relevant market.

Accept Artwork I Reject Artwork

(Please strike off whichever NOT applicable)

Signature....­.............­.............­.............­.............­...........

Name.........­.............­.............­.............­.............­............

Date.........­.............­.............­.............­.............­..............

PAGE 1 OF 1